logo
logo

Tentarix Biotherapeutics Emerges With $50 Million Series A

Oct 14, 2021•almost 4 years ago

Amount Raised

$50 Million

Round Type

series a

San Diego

Description

Biotechnology company Tentarix Biotherapeutics LP today announced a $50 million Series A investment co-led by Versant Ventures and Samsara BioCapital.

Company Information

Company

Tentarix

Location

San Diego, California, United States

About

Tentarix’s mission is to develop first-in-class targeted, multifunctional, conditional therapies. The Company is focused on modalities that have cell specific function and has built a team that aims to transform biologics. For more information, please visit www.tentarix.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech